Plasma BACE1 concentration is a novel core candidate biomarker potentially serving for different context(s) of use to enrich both clinical diagnostic-prognostic workup and pharmacological trials for early Aβ-targeted therapies for AD. To investigate the question whether and how BACE1 expression levels (reflected by plasma concentrations) are…
Home Alzheimer's Research Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in...
Latest article
Take it from the rats: A junk food diet can cause long-term damage to...
A new USC-led study on rats that feasted on a high-fat, sugary diet raises the possibility that a junk food-filled diet in teens may...
Repurposing non-pharmacological interventions for Alzheimer’s disease through link prediction on biomedical literature
The complete workflow is depicted in Fig. 1. To investigate the association between NPIs and AD, we initially conducted preprocessing and integration of biomedical triples...
Degenerative Dementias and Their Medical Care in the Movies
Compared with other neurologic problems, few films have been dedicated to degenerative dementia. To our knowledge, this is the first systematic review about the...
